Image

Developing a Scalable Tobacco Cessation Program for Cancer Survivors and Caregivers

Developing a Scalable Tobacco Cessation Program for Cancer Survivors and Caregivers

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Given the challenges to delivering tobacco cessation treatment in oncology care and the unique challenges faced by individuals attempting to quit tobacco after a cancer diagnosis, scalable cessation programs that are tailored to the experiences of cancer survivors that also integrate caregiver/family support are needed. To address this need, this study will use an intervention that consists of two primary strategies: 1) a tailored cessation program for cancer survivors and family members/caregivers who use tobacco and 2) healthcare provider training.

Healthcare providers will receive training on the AAC model (Ask patients about tobacco use, Advise patients to quit, Connect patients to cessation resources), including materials focused on tobacco cessation in cancer care from the CDC, as well as a brief evidence-based communication skills training based on the C-LEAR (Counsel, Listen, Empathize, Answer, Recommend) approach.

Eligibility

Inclusion Criteria:

Cancer Survivors including Current Cancer Patients

  • Current self-reported user of any tobacco/nicotine product at time of baseline screening assessment (e.g., cigarettes, e-cigarettes, cigars, dip/chew) in the past month.
  • Any history of cancer diagnosis. Subjects currently receiving cancer-related treatments are eligible for enrollment.
  • Receiving care from the participating UF Health clinics (Medical Oncology, Urology, and Radiation Oncology).
  • Capable of completing study requirements
  • Informed consent obtained from the subject and documentation of subject agreement to comply with all study-related processes
  • Adults aged ≥18 years

Informal Caregivers/Family Members of Cancer Survivors

  • Current self-reported user of any tobacco/nicotine product at time of baseline screening assessment (e.g., cigarettes, e-cigarettes, cigars, dip/chew) in the past month.
  • A family member, informal caregiver, or friend of an enrolled cancer survivor receiving care from the participating UF Health clinics as described above
  • Capable of completing study requirements
  • Informed consent obtained from the subject and documentation of subject agreement to comply with all study-related processes
  • Adults aged ≥18 years

Exclusion Criteria:

Cancer Survivors including Current Cancer Patients

  • Patients unable to complete the sessions because of language, travel or technology barriers
  • Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness.

Informal Caregivers/Family Members of Cancer Survivors

  • Participants unable to complete the sessions because of language, travel or technology barriers
  • Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness.

Study details
    Nicotine Use
    Tobacco Use

NCT06851936

University of Florida

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.